About Lung-MAP: Leadership

LUNG-MAP Study Chairs

• SWOG: (Chair) Karen Reckamp, M.D
• NRG: (Vice Chair) Saiama Waqar, M.D.

Lung-MAP Statistical Chair

• SWOG: Mary W. Redman, Ph.D.

Lung-MAP Chair Emeritus and Senior Advisor

• SWOG: Roy Herbst, M.D., Ph.D.

Medical Oncology Chairs/Champions

• SWOG: David R. Gandara, M.D.
• SWOG:  John Wrangle, M.D.
• Alliance: Konstantin Dragnev, M.D.
• Alliance: Jyoti D. Patel, M.D.
• ECOG-ACRIN: Joel Neal, M.D., Ph.D.
• ECOG-ACRIN: Ticiana Leal, M.D.
• NRG: Martin Edelman, M.D.
• NRG: Anjali Rohatgi, M.D.

Lung Cooperative Group Chairs

• SWOG: Jhanelle E. Gray, M.D.
• Alliance: Thomas Stinchcombe, M.D.
• ECOG-ACRIN: Julie R. Brahmer, M.D.
• NRG: Jeff Bradley, M.D.

Translational Medicine Chair

• ECOG-ACRIN: Joel Neal, M.D., Ph.D.

Biostatisticians

• SWOG: Katherine Minichiello, M.S.  
• SWOG/TM: Michael Wu, Ph.D.    

Imaging Chair

• SWOG/Alliance: Lawrence H. Schwartz, M.D.

Lung-MAP Trial Oversight Committee

• (Co-Chair) Karen Reckamp, Director, Division of Medical Oncology/ Associate Director of Clinical Research, Cedars-Sinai – SWOG
• (Co-Chair) Ellen Sigal, Chairperson and Founder, Friends of Cancer Research
• (Co-Chair) Vincent Miller, Physician-in-Chief, Advisor
• Renzo Canetta, Ex-officio Member
• Bryan Faller, Missouri Baptist Medical Center
• Gwen Fyfe, Former Vice President, Oncology Department, Genentech
• Gary Gilliland, President and Director Emeritus,
• Fred Hutchinson Cancer Research Center
• Gary Kelloff, Special Advisor, NCI-DCTD
• Lisa LaVange, University of North Carolina
• Christine Lovly, Vanderbilt University Medical Center
• Liza Villaruz, University of Pittsburgh Cancer Institute
• Kim Norris, Founder and President, Lung Cancer Foundation of America

Lung-MAP Drug Selection Committee

• (Chair) Konstantin Dragnev, M.D., Dartmouth Cancer Center – Alliance

Voting members include representatives from each of the participating NCTN groups, FDA, NCI, Friends of Cancer Research, FNIH, key opinion leaders from academia, and drug developers from industry (retired, consultants, or not from companies participating or potentially participating in Lung-MAP).

NIH/NCI

• Margaret Mooney, MD, Associate Director, Cancer Therapy Evaluation Program
• Shakun Malik, MD, Head of Thoracic Oncology Therapeutics, Cancer Therapy Evaluation Program

Lung-MAP Accrual Enhancement Committee

• Stacey Adam, Ph.D., Vice President, Science Partnerships, Foundation for the National Institutes of Health
• Andrea Denicoff, RN, M.S., ANP, Head, National Clinical Trials Network, Clinical Trials Operations, National Cancer Institute, Division of Cancer Treatment and Diagnosis, Cancer Therapy Evaluation Program
• Frank DeSanto, MFA,(Vice Chair), Communications and Public Relations Manager, SWOG
• Taqwa El-Hussein, Project Manager, Cancer, Foundation for the National Institutes of Health
• Lucy Gansauer, MSN, RN, OCN, CCRP, SWOG Lung Committee, Diversity, Equity, and Inclusion Champion, (Advocate)
• Ryan Hohman, JD, MPA (Chair), Vice President, Public Affairs, Friends of Cancer Research
• Judy Johnson, MBA, SWOG, Lung Committee, National Cancer Institute Thoracic Malignancy Steering Committee, National Cancer Institute Patient Advocate Steering Committee, National Cancer Institute National Clinical Trials Network, Core Correlative Sciences Committee B, (Advocate)
• Jennifer Newsome, M.S., Senior Project Manager, Cancer, Foundation for the National Institutes of Health
• Jennifer Pope, CCRP, Clinical Trials Team Manager, Yale University Cancer Center
• Stephanie (Smith) Reyes, MSN, RN, OCN, Clinical Research Manager, St. Joseph’s Candler Health System, Charleston Southern University, Savannah, Georgia
• Caroline Sigman, Ph.D., President, CCS Associates
• Amanda Stamplis, MPH, Plain Language Writer, SWOG
• Jamie Sundstrom, Clinical Trials Recruitment and Retention Specialist, SWOG, Cancer Research and Biostatistics